Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy.
Mathis S et al. Cytometry B Clin Cytom. 2014 Oct 28. doi: 10.1002/cytob.21200. [Epub ahead of print].

Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agents.
Jimenez-Zepeda VH et al. Bone Marrow Transplant. 2014 Oct 27. doi: 10.1038/bmt.2014.237. [Epub ahead of print].

Red Cell Distribution Width and Other Red Blood Cell Parameters in Patients with Cancer: Association with Risk of Venous Thromboembolism and Mortality.
Riedl J et al. PLoS One. 2014 Oct 27;9(10):e111440. doi: 10.1371/journal.pone.0111440. eCollection 2014.

The importance of screening for serum free light chains in suspected cases of multiple myeloma and their impact on the kidney.
Talbot B et al. BMJ Case Rep. 2014 Oct 17;2014. pii: bcr2014206688. doi: 10.1136/bcr-2014-206688.

Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease.
Dowling P et al. BMC Genomics. 2014 Oct 17;15(1):904. [Epub ahead of print].

Prognostic parameters and spinal metastases: a research study.
Daniel JW et al. PLoS One. 2014 Oct 13;9(10):e109579. doi: 10.1371/journal.pone.0109579. eCollection 2014.

State of the art imaging of multiple myeloma: Comparative review of FDG PET/CT imaging in various clinical settings.
Mesguich C et al. Eur J Radiol. 2014 Sep 28. pii: S0720-048X(14)00455-0. doi: 10.1016/j.ejrad.2014.09.012. [Epub ahead of print].

Differences Identified between Serum and Urine Immunofixation Electrophoresis.
Tracy E et al.Clin Chim Acta. 2014 Oct 9. pii: S0009-8981(14)00433-1. doi: 10.1016/j.cca.2014.10.002. [Epub ahead of print].

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.
Silvennoinen R et al. Blood Cancer J. 2014 Oct 10;4:e250. doi: 10.1038/bcj.2014.69.

The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease.
Yadav P et al. Kidney Int. 2014 Oct 8. doi: 10.1038/ki.2014.333. [Epub ahead of print].

Whole-Body Low-Dose Computed Tomography and Advanced Imaging Techniques for Multiple Myeloma Bone Disease.
Pianko MJ et al. Clin Cancer Res. 2014 Oct 7. pii: clincanres.1692.2014. [Epub ahead of print].

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma.
Boyle EM et al. Genes Chromosomes Cancer. 2014 Oct 7. doi: 10.1002/gcc.22222. [Epub ahead of print].

The Prognostic Impact of Peripheral Blood Progenitor Cell Dose Following High-Dose Therapy and Autologous Stem Cell Transplantation for Hematologic Malignancies.
Sauter CS et al. Leuk Lymphoma. 2014 Oct 6:1-22. [Epub ahead of print].

Antigen Expression Patterns of Plasma Cell Myeloma: An Association of Cytogenetic Abnormality and International Staging System (ISS) for Myeloma.
Shin SY et al. J Clin Lab Anal. 2014 Oct 2. doi: 10.1002/jcla.21801. [Epub ahead of print].

Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
Nieters A et al. Carcinogenesis. 2014 Sep 30. pii: bgu188. [Epub ahead of print].

Tumor Load in Patients With Multiple Myeloma: β2-Microglobulin Levels Versus Whole-Body MRI.
D’Anastasi M et al. AJR Am J Roentgenol. 2014 Oct;203(4):854-62. doi: 10.2214/AJR.13.10724.

Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs.
Napolitano M et al. Leuk Lymphoma. 2014 Oct 7:1-3. [Epub ahead of print].

Changes in circulating endothelial cells count could become a valuable tool in the diagnostic definition of acute graft-versus-host disease.
Almici C et al. Transplantation. 2014 Oct 15;98(7):706-12. doi: 10.1097/TP.0000000000000385.

Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.
Agostinelli C et al. Am J Surg Pathol. 2014 Oct;38(10):1349-59. doi: 10.1097/PAS.0000000000000309.